论文信息 - Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial - 字舞流文

Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial

T. Delozier | J. Julien | C. Veyret | J. Ollivier | Y. Graic | P. Juret | J. Couëtte | Edith de Ranieri | E. Ranieri

[1] G. Mead,et al. Adjuvant tamoxifen for operable carcinoma of the breast , 1983 .

[2] M. Baum,et al. CONTROLLED TRIAL OF TAMOXIFEN AS ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER Interim Analysis at Four Years by Nolvadex Adjuvant Trial Organisation , 1983, The Lancet.

[3] C. Redmond,et al. Treatment of primary breast cancer with chemotherapy and tamoxifen. , 1981, The New England journal of medicine.

[4] R. S. Rhodes,et al. Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45‐month follow‐up of a prospective, randomized clinical trial , 1980, Cancer.

[5] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .

[6] W. McGuire,et al. Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year results , 2005, Breast Cancer Research and Treatment.

[7] B. Fisher,et al. Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen: An interim report , 2005, Breast Cancer Research and Treatment.

[8] C. Watson,et al. Heterogeneity of estrogen binding sites in mammary tumors , 2005, Breast Cancer Research and Treatment.